Evidence map›Paper›PMID 41097716›Full record

ReviewCancers2025

Impact of Somatic Gene Mutations on Prognosis Prediction in De Novo AML: Unraveling Insights from a Systematic Review and Meta-Analysis.

Amal Elfatih, Nisar Ahmed, Luma Srour, Idris Mohammed, William Villiers, Tara Al-Barazenji, Hamdi Mbarek, Susanna El Akiki, Puthen Veettil Jithesh, Mohammed Muneer and 2 more

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amal ElfatihGenomics and Precision Medicine, College of Health and Life Science, Hamad Bin Khalifa University, Doha 34110, Qatar.ORCID 0000-0002-4783-1384
Nisar AhmedGenomics and Precision Medicine, College of Health and Life Science, Hamad Bin Khalifa University, Doha 34110, Qatar.
Luma SrourGenomics and Precision Medicine, College of Health and Life Science, Hamad Bin Khalifa University, Doha 34110, Qatar.ORCID 0000-0002-5585-4455
Idris MohammedGenomics and Precision Medicine, College of Health and Life Science, Hamad Bin Khalifa University, Doha 34110, Qatar.ORCID 0000-0002-8983-0929
William VilliersGenomics and Precision Medicine, College of Health and Life Science, Hamad Bin Khalifa University, Doha 34110, Qatar.
Tara Al-BarazenjiDepartment of Biomedical Sciences, College of Health Sciences, Qatar University, Doha 2713, Qatar.
Hamdi MbarekQatar Precision Health Institute, Doha 5825, Qatar.
Susanna El AkikiDepartment of Biomedical Sciences, College of Health Sciences, Qatar University, Doha 2713, Qatar.
Puthen Veettil JitheshGenomics and Precision Medicine, College of Health and Life Science, Hamad Bin Khalifa University, Doha 34110, Qatar.ORCID 0000-0001-7747-0930
Mohammed MuneerDepartment of Plastic Surgery, Hamad Medical Corporation, Doha 3050, Qatar.
Shehab FareedHematology Department, NCCCR, Hamad Medical Corporation, Doha 3050, Qatar.
Borbala MifsudGenomics and Precision Medicine, College of Health and Life Science, Hamad Bin Khalifa University, Doha 34110, Qatar.ORCID 0000-0003-3429-3094

Funding

QRDI Qatar National Research Funds (QNRF) -National Priority Research Program (NPRP) NPRP13S-0116-200088.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute myeloid leukemiaoverall survivalrelapse free survivalsomatic mutation

Identifiers

PMID41097716
PMCPMC12523279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.